Literature DB >> 11266310

Strengthening national preparedness for smallpox: an update.

J W LeDuc1, P B Jahrling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11266310      PMCID： PMC2631676          DOI： 10.3201/eid0701.700155

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


× No keyword cloud information.
  2 in total

1.  Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses.

Authors:  S N Shchelkunov; R F Massung; J J Esposito
Journal:  Virus Res       Date:  1995-04       Impact factor: 3.303

2.  Current status of smallpox vaccine.

Authors:  J W LeDuc; J Becher
Journal:  Emerg Infect Dis       Date:  1999 Jul-Aug       Impact factor: 6.883
  2 in total
  14 in total

1.  Detection of smallpox virus DNA by LightCycler PCR.

Authors:  Mark J Espy; Franklin R Cockerill III; Richard F Meyer; Michael D Bowen; Gregory A Poland; Ted L Hadfield; Thomas F Smith
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 2.  [Bioterrorism and primary care].

Authors:  M A Mayer Pujadas; M J Alvarez Pasquín; J Gómez Marco; J Redondo Sánchez; J Muñoz Gutiérrez; M Cereceda Ferrés; C Batalla Martínez; E Comín Bertrán; A Pareja Bezares; R Piñeiro Guerrero; V Niño Martín; J Arranz Izquierdo; P Carceller; E Nodar Martín; J Ortega Martínez; J Vázquez Villegas
Journal:  Aten Primaria       Date:  2002-10-15       Impact factor: 1.137

3.  Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.

Authors:  Megan M McCausland; Mohammed Rafii-El-Idrissi Benhnia; Lindsay Crickard; John Laudenslager; Steven W Granger; Tomoyuki Tahara; Ralph Kubo; Lilia Koriazova; Shinichiro Kato; Shane Crotty
Journal:  Antivir Ther       Date:  2010

Review 4.  The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data.

Authors:  M Shannon Keckler; Mary G Reynolds; Inger K Damon; Kevin L Karem
Journal:  Vaccine       Date:  2013-08-27       Impact factor: 3.641

Review 5.  Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.

Authors:  Stephen R Walsh; Raphael Dolin
Journal:  Expert Rev Vaccines       Date:  2011-08       Impact factor: 5.217

6.  Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.

Authors:  Debra C Quenelle; Deborah J Collins; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

7.  Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox.

Authors:  Peter B Jahrling; Lisa E Hensley; Mark J Martinez; James W Leduc; Kathleen H Rubins; David A Relman; John W Huggins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

8.  Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.

Authors:  Debra C Quenelle; Deborah J Collins; W Brad Wan; James R Beadle; Karl Y Hostetler; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

9.  Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjects.

Authors:  Robert Jordan; Jarasvech Chinsangaram; Tove' C Bolken; Shanthakumar R Tyavanagimatt; Deborah Tien; Kevin F Jones; Annie Frimm; Michael L Corrado; Margaret Pickens; Patrick Landis; Jean Clarke; Thomas C Marbury; Dennis E Hruby
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.938

10.  Smallpox research activities: U.S. interagency collaboration, 2001.

Authors:  James W LeDuc; Inger Damon; David A Relman; John Huggins; Peter B Jahrling
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.